Early assessment with (18)F-2-fluoro-2-deoxyglucose positron emission tomography/computed tomography to predict short-term outcome in clear cell renal carcinoma treated with nivolumab

BACKGROUND: We reported previously the usefulness of 18F-2-fluoro-2-deoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) to predict prognosis of renal cell carcinoma (RCC) treated with molecular targeted agents. Herein we describe a preliminary research of nine patients who und...

Descripción completa

Detalles Bibliográficos
Autores principales: Tabei, Tadashi, Nakaigawa, Noboru, Kaneta, Tomohiro, Ikeda, Ichiro, Kondo, Keiichi, Makiyama, Kazuhide, Hasumi, Hisashi, Hayashi, Narihiko, Kawahara, Takashi, Izumi, Koji, Osaka, Kimito, Muraoka, Kentaro, Teranishi, Jun-ichi, Miyoshi, Yasuhide, Yumura, Yasushi, Uemura, Hiroji, Kobayashi, Kazuki, Inoue, Tomio, Yao, Masahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446392/
https://www.ncbi.nlm.nih.gov/pubmed/30940117
http://dx.doi.org/10.1186/s12885-019-5510-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446392/
https://www.ncbi.nlm.nih.gov/pubmed/30940117
http://dx.doi.org/10.1186/s12885-019-5510-y

Ejemplares similares